Alcidion GroupASX:ALC 50 Return-on-Tangible-Equity is Negative Tangible Equity% as of Dec. 2025. GuruFocus rates ASX:ALC with a GF Score™ of 50/100 and a GF Value™ of A$0.12 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 582 Healthcare Providers & Services companies, Alcidion Group ranks better than 99.83% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Alcidion Group's annualized net income for the quarter that ended in Dec. 2025 was A$2.66 Mil. Alcidion Group's average shareholder tangible equity for the quarter that ended in Dec. 2025 was A$-0.69 Mil. Therefore, Alcidion Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was Negative Tangible Equity%.
The historical rank and industry rank for Alcidion Group's Return-on-Tangible-Equity or its related term are showing as below:
ASX:ALC'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -68.59 Med: -49.33 Max: -14.93
Current: Negative Tangible Equity
During the past 13 years, Alcidion Group's highest Return-on-Tangible-Equity was -14.93%. The lowest was -68.59%. And the median was -49.33%.
ASX:ALC's Return-on-Tangible-Equity is ranked better than 99.83% of 582
companies
in the Healthcare Providers & Services industry
Industry Median: 9.965
vs ASX:ALC: Negative Tangible Equity
Alcidion Group (ASX:ALC) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Alcidion Group Return-on-Tangible-Equity Related Terms
Alcidion Group Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Alcidion Group's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:ALC vs VEEV, BTSG, TEM: Return-on-Tangible-Equity Comparison
For the Health Information Services subindustry, Alcidion Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alcidion Group Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alcidion Group's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Alcidion Group's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of Negative Tangible Equity% mean?
Alcidion Group (ASX:ALC) has a Return-on-Tangible-Equity of Negative Tangible Equity% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Alcidion Group and its competitors. According to the industry distribution chart, Alcidion Group ranks #1 out of 582 companies in the Healthcare Providers & Services industry, placing it in the top 0.2%.
Is Alcidion Group's Return-on-Tangible-Equity too high?
Alcidion Group's current Return-on-Tangible-Equity is Negative Tangible Equity%. Based on the distribution chart, Alcidion Group ranks #1 out of 582 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Alcidion Group has a GF Score™ of 50/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alcidion Group's Return-on-Tangible-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Alcidion Group ranks #1 out of 582 companies for Return-on-Tangible-Equity. This places Alcidion Group in the top 0% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 9.97. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 9.97, based on 582 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Alcidion Group and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 9.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alcidion Group's current Return-on-Tangible-Equity is Negative Tangible Equity%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alcidion Group stock overvalued right now?
Based on GuruFocus' analysis, Alcidion Group (ASX:ALC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.12, compared to a current price of A$0.11 — trading 12.5% below its estimated fair value. The current Return-on-Tangible-Equity is Negative Tangible Equity%. Alcidion Group's overall GF Score™ is 50/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Alcidion Group (ASX:ALC), the current Return-on-Tangible-Equity is Negative Tangible Equity% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alcidion Group (ASX:ALC) Overvalued in 2026?
Based on GuruFocus' analysis, Alcidion Group stock appears to be undervalued.
The current stock price of A$0.11 is trading 12.5% below its estimated GF Value™ of A$0.12.
GuruFocus considers Alcidion Group to be Modestly Undervalued.
No single metric tells the full story. See the ASX:ALC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alcidion Group Ltd is a provider of intelligent informatics software. It offers a fully integrated digital patient care platform that includes a clinical decision support (CDS) system, Electronic Patient Record (EPR), and Patient Administration System (PAS). Alcidion is engaged in the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of healthcare software products from its strategic partners, and the delivery of product implementation, product support and maintenance, systems integration and data analysis services to healthcare customers in the United Kingdom, Australia, and New Zealand. The company generates maximum revenue from the United Kingdom.
50GF Score
Get the complete analysis for ASX:ALC
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ALC has been successfully added to your 
